Patient-ventilator Synchronisation Study for Intensive Care Unit Patients (SyncAutoVNI)

Patient-ventilator Synchronisation Study in Non Invasive Ventilation for Intensive Care Unit Patients: Comparison Between Manual and Automated Ventilator Settings.

This cross-over study will compare the asynchrony index between standard manual ventilator settings, optimized manual ventilator settings, and automated ventilator setting in intensive care patients ventilated in non-invasive ventilation with a high asynchrony index. The hypothesis is that both manual optimized ventilator settings and automated ventilator settings are associated with a lower patient-ventilator asynchrony index as compared to manual standard ventilator settings.

A randomized cross-over design method will be used. Patient requiring NIV with an asynchrony index over 35% will be included. An esophageal catheter with a balloon will be inserted to monitor esophageal pressure. Patients will be ventilated during 3 periods of 30 min, with 10 minutes of washout in between. Recordings of airway pressure, airway flow, and esophageal pressure will be analyzed by two investigators blinded of the trigger settings.

The primary outcome will be the asynchrony index. The secondary outcome will be the ineffective inspiratory effort index, autotrigering index, double triggering index, inspiratory trigger delay, cycling delay, total time spent in asynchrony, patient comfort, and blood gas results.

Study Overview

Status

Recruiting

Detailed Description

Non-invasive ventilation (NIV) is used in 35% of patient admitted in intensive care unit (ICU) with a failure rate of 10 to 70% depending on the indication and clinician experience. Patient-ventilator asynchrony is a frequent cause of NIV failure. Therefore, optimizing patient-ventilator synchronization is important for its comfort, tolerance, and efficacy. An optimal patient-ventilation is achieved when the mechanical breath provided by the ventilator match the patient inspiratory effort. The ratio between the number of asynchronies divided by the number of patient inspiratory effort define the asynchrony index (AI). AI over 10% is considered as severe and occurs in 30 to 43% of patients ventilated in NIV. Patient ventilator asynchronies occurs because ventilator settings of inspiratory and expiratory triggers remain constant in patient with variable respiratory drive, and unintentionnals leaks that are difficult to control in NIV. Thus using an automatic adjustment of inspiratory and expiratory triggers setting according to patient effort and unintentional leaks may decrease the number of patient-ventilator asynchronies. This cross-over study will compare the asynchrony index between standard manual ventilator settings, optimized manual ventilator settings, and automated ventilator setting in intensive care patients ventilated in non-invasive ventilation with a high asynchrony index. The hypothesis is that both manual optimized ventilator settings and automated ventilator settings are associated with a lower patient-ventilator asynchrony index as compared to manual standard ventilator settings.

A randomized cross-over design method will be used. Patient requiring NIV with an asynchrony index over 30% will be included. An esophageal catheter with a balloon will be inserted to monitor esophageal pressure. Patients will be ventilated during 3 periods of 30 min, with 10 minutes of washout in between. Recordings of airway pressure, airway flow, and esophageal pressure will be analyzed by two investigators blinded of the trigger settings.

The primary outcome will be the asynchrony index. The secondary outcome will be the ineffective inspiratory effort index, autotrigering index, double triggering index, inspiratory trigger delay, cycling delay, total time spent in asynchrony, patient comfort, and blood gas results.

The sample size was calculated from the total asynchrony index (primary outcome). Patients with an asynchrony index over 30% in using manual standard ventilator settings will be included. Considering an asynchrony index of 30 ± 15 % in manual standard ventilator settings with a clinically significant objective to reduce the asynchrony index to 15% in manual optimized ventilator settings and automated ventilator settings, a sample size of 30 patients is required with a risk at 0.05 and a power at 80%. Therefore, 35 patients are planned.

Study Type

Interventional

Enrollment (Estimated)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Var
      • Toulon, Var, France, 83056
        • Recruiting
        • Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
        • Contact:
        • Sub-Investigator:
          • Jean-Michel Arnal, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient aged over 18 years old
  • Covered by social insurance
  • Consent for study signed by patient or next-of-kin
  • NIV session indicated for at least 2 hours
  • Asynchrony index ≥ 30% with standard manual settings

Exclusion Criteria:

  • Patient requiring continuous NIV
  • Contra-indication to esophageal catheter insertion: gastric ulcer, esophageal varices, pharyngeal or laryngeal tumor.
  • Patient with withholding decision about intubation
  • Moribund patient
  • Patient included in another interventional study in the last 30 days
  • Patient that does not speak French
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Manual standard ventilator settings
Inspiratory trigger set at 2 l/min, Expiratory trigger set at 25% of peak inspiratory flow
Active Comparator: Manual optimized ventilator settings
Inspiratory trigger and Expiratory trigger settings optimized by investigator
Inspiratory trigger and Expiratory trigger settings optimized by investigator
Experimental: Automated ventilator settings
Inspiratory trigger and Expiratory trigger settings automatized
Inspiratory trigger and Expiratory trigger settings automatized

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asynchrony index
Time Frame: Continuous measurement over 30min
Ratio between the total number of asynchronies divided by the number of patient inspiratory effort
Continuous measurement over 30min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lineffective inspiratory effort index
Time Frame: Continuous measurement over 30min
Ratio between the total number of ineffective inspiratory effort divided by the number of patient inspiratory effort
Continuous measurement over 30min
Autotrigering index
Time Frame: Continuous measurement over 30min
Ratio between the total number of autotriggered breath divided by the number of patient inspiratory effort
Continuous measurement over 30min
Double triggering index
Time Frame: Continuous measurement over 30min
Ratio between the total number of double triggered breath divided by the number of patient inspiratory effort
Continuous measurement over 30min
Inspiratory trigger delay
Time Frame: Continuous measurement over 30min
Time between the beginning of patient effort assessed on oesophageal pressure and beginning of mechanical breath.
Continuous measurement over 30min
Cycling delay
Time Frame: Continuous measurement over 30min
Time between the end of patient effort assessed on oesophageal pressure and the end of mechanical breath.
Continuous measurement over 30min
Total time spent in asynchrony
Time Frame: Continuous measurement over 30min
Ratio of total time of ineffective inspiratory effort, inspiratory trigger delay, and cycling delay on total time of recording.
Continuous measurement over 30min
Patient comfort
Time Frame: 1 day (Single measurement)
Visual analog scale of Likert type measuring patient comfort going from 0 (very uncomfortable) to 10 (very comfortable)
1 day (Single measurement)
Blood PaO2 results
Time Frame: After each period at 30 min, 1 h and 1 h 30 min
PaO2
After each period at 30 min, 1 h and 1 h 30 min
Blood PaCO2 results
Time Frame: After each period at 30 min, 1 h and 1 h 30 min
PaCO2
After each period at 30 min, 1 h and 1 h 30 min
Blood pH results
Time Frame: After each period at 30 min, 1 h and 1 h 30 min
pH
After each period at 30 min, 1 h and 1 h 30 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Aude Garnero, MD, Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2019

Primary Completion (Estimated)

April 16, 2024

Study Completion (Estimated)

April 16, 2024

Study Registration Dates

First Submitted

December 20, 2018

First Submitted That Met QC Criteria

December 24, 2018

First Posted (Actual)

December 26, 2018

Study Record Updates

Last Update Posted (Actual)

April 1, 2024

Last Update Submitted That Met QC Criteria

March 29, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-CHITS-01
  • 2018-A00658-47 (Other Identifier: Id-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Failure

Clinical Trials on Optimized

3
Subscribe